Expansion of revenue and profit
First written in FY2018-Q3. 13 of 42 entries say "Worsened", first in FY2020-Q2. Latest entry: 2026-10-13.
Signpost moved to the "Worse" side of this theme in 2020, 4 years before the typical company in this theme (2024).
The whole theme swung hardest in 2026: 19 of 79 companies on the "Worse" side.
9 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「As a result, net sales amounted to ¥1,892 million, up 30.2% year on year, mainly because orders received by the consulting business remained solid. In terms of earnings, gross profit increased mainly because of higher revenue from the consulting business, resulting in operating profit of ¥76 million, compared with an operating loss of ¥20 million in the same period of the previous year, and ordinary profit of ¥76 million, compared with an ordinary loss of ¥25 million.」
Net sales increased 30.2% year on year, mainly because of orders received by the consulting business, while operating profit and ordinary profit turned profitable from losses in the same period of the previous year. - 2026-07-10AdvancedEarnings
「As a result, revenue was ¥908 million, up 29.2% year on year, due in part to solid orders in the consulting business.」
First-quarter revenue increased 29.2% year on year. The operating loss narrowed from ¥19 million in the same quarter of the previous year to ¥2 million, while expenses increased due to hiring and training and personnel expenses in sales and administrative departments. - FY2026WorsenedAnnual report
「As a result, net sales amounted to ¥3,138 million (up 3.8% from the previous fiscal year). In terms of earnings, although gross profit increased mainly due to higher consulting-business revenue, higher costs related to developing Global GO! Smooth EC and generative AI tools, as well as higher personnel expenses for sales activities and business development, increased selling, general and administrative expenses, resulting in operating profit of ¥98 million (down 50.8%), ordinary profit of ¥92 million (down 53.2%) and net profit of ¥76 million (down 70.4%).」
While net sales increased, operating profit, ordinary profit and net profit all declined substantially year on year due to higher EC and generative AI development costs and higher personnel expenses for sales and business development. - FY2026-H1WorsenedAnnual report
「As a result, net sales amounted to ¥1,453 million (down 2.1% year on year), as utilization in the consulting business temporarily declined in the first quarter following the completion of a large-scale project, although orders subsequently increased steadily through sales activities. In terms of earnings, although lower outsourcing expenses increased gross profit, higher recruiting expenses, outsourcing expenses related to solution development and personnel expenses due to increases in sales and indirect staff resulted in an operating loss of ¥20 million (compared with operating profit of ¥82 million in the same period of the previous year). An ordinary loss of ¥25 million (compared with ordinary profit of ¥81 million) resulted from the recognition of bond issuance costs associated with financing, and interim net loss was ¥26 million (compared with interim net profit of ¥78 million).」
From profits in the same period of the previous year, net sales fell 2.1% and operating, ordinary and interim net profit changed to losses. Higher recruiting expenses, solution development costs, personnel expenses and bond issuance costs are cited as factors. - FY2025AdvancedAnnual report
「As a result, net sales amounted to ¥3,023 million (up 3.2% from the previous fiscal year). In terms of earnings, although expenses increased in the fourth quarter due to measures to strengthen mid-career hiring and the development of new solutions, full-year gross profit increased due to higher sales, resulting in operating profit of ¥200 million (up 96.6% year on year) and ordinary profit of ¥197 million (up 108.5%). Net profit was ¥257 million (up 99.7%), due partly to the recognition of a ¥62 million tax adjustment gain.」
Full-year net sales amounted to ¥3,023 million, operating profit to ¥200 million, ordinary profit to ¥197 million and net profit to ¥257 million, with higher sales and higher profit continuing. - FY2025-H1AdvancedAnnual report
「As a result, net sales amounted to ¥1,485 million (up 7.2% year on year). In terms of earnings, higher sales increased gross profit and lower selling, general and administrative expenses resulted in operating profit of ¥82 million (compared with operating loss of ¥29 million in the same period of the previous year), ordinary profit of ¥81 million (compared with ordinary loss of ¥30 million) and interim net profit of ¥78 million (compared with interim net loss of ¥41 million).」
Interim net sales increased 7.2% year on year, and operating profit of ¥82 million, ordinary profit of ¥81 million and interim net profit of ¥78 million represented a change from losses in the same period of the previous year to profits. - FY2025-Q1AdvancedAnnual report
「As a result, net sales amounted to ¥745 million (up 13.4% year on year). In terms of earnings, higher sales increased gross profit and lower selling, general and administrative expenses resulted in operating profit of ¥29 million (compared with operating loss of ¥38 million in the same quarter of the previous year), ordinary profit of ¥28 million (compared with ordinary loss of ¥38 million) and quarterly net profit of ¥26 million (compared with quarterly net loss of ¥44 million).」
Net sales increased 13.4% year on year, and operating, ordinary and quarterly net profit changed from losses in the same period of the previous year to profits. - FY2024AdvancedAnnual report
「As a result, net sales for the fiscal year amounted to ¥2,929 million (up 13.8% from the previous fiscal year). In terms of earnings, operating profit of ¥101 million (compared with operating loss of ¥110 million in the previous fiscal year) was achieved mainly by controlling selling, general and administrative expenses through the effect of higher consulting-business revenue, fixed-cost reductions and lower taxes and dues. Ordinary profit was ¥94 million (compared with ordinary loss of ¥119 million), and net profit was ¥128 million (compared with net loss of ¥132 million).」
Net sales increased 13.8% from the previous fiscal year to ¥2,929 million, and operating profit, ordinary profit and net profit all changed to profits. - FY2024-Q3Higher sales, return to operating profit, ordinary profit and narrower net lossAnnual report
「Net sales amounted to ¥2,156 million (up 12.2% year on year). In terms of earnings, the effect of higher consulting-business revenue, progress in contract development work in the innovation business and control of selling, general and administrative expenses resulted in operating profit of ¥15 million (compared with operating loss of ¥79 million in the same quarter of the previous year), ordinary profit of ¥13 million (compared with ordinary loss of ¥87 million) and quarterly net loss of ¥6 million (compared with quarterly net loss of ¥99 million).」
Net sales increased for the nine months ended the third quarter, operating and ordinary profit changed to a profit, and net loss narrowed. However, quarterly net loss continued. - FY2024-Q2Higher sales, narrower losses and quarterly operating profitAnnual report
「As a result, net sales for the six months ended the second quarter amounted to ¥1,385 million (up 9.4% year on year). In the three months of the second quarter accounting period (June to August), operating profit changed to a profit due to the effect of higher consulting-business revenue, progress in contract development work in the innovation business and control of selling, general and administrative expenses. For the six-month cumulative period (March to August), however, the decline in gross profit, mainly due to lower revenue from the innovation business, resulted in an operating loss of ¥29 million (compared with operating loss of ¥52 million in the same quarter of the previous year), ordinary loss of ¥30 million (compared with operating loss of ¥59 million) and quarterly net loss of ¥41 million (compared with quarterly net loss of ¥69 million), due to a decrease in income taxes and other taxes.」
Net sales increased for the cumulative period, and operating, ordinary and net losses all narrowed from the same period of the previous year. In addition, operating profit for the second quarter accounting period changed to a profit. - FY2024-Q1Higher sales, wider operating lossAnnual report
「As a result, net sales for the three months ended the first quarter amounted to ¥657 million (up 6.1% year on year). In terms of earnings, the decline in gross profit due mainly to lower revenue from the innovation business resulted in an operating loss of ¥38 million (compared with operating loss of ¥35 million in the same quarter of the previous year), ordinary loss of ¥38 million (compared with operating loss of ¥36 million) and quarterly net loss of ¥44 million (unchanged from the same quarter of the previous year).」
While net sales increased 6.1% year on year, operating and ordinary losses widened from the same quarter of the previous year due mainly to lower revenue from the innovation business, while net loss remained nearly unchanged. - FY2023Revenue Growth and Reduced LossesAnnual report
「As a result, net sales for the fiscal year amounted to ¥2,574 million (up 21.5% from the previous fiscal year). In terms of earnings, higher sales increased gross profit, while lower selling, general and administrative expenses, mainly due to reduced research and development and recruiting expenses, resulted in an operating loss of ¥110 million (compared with operating loss of ¥378 million in the previous fiscal year), ordinary loss of ¥119 million (compared with ordinary loss of ¥382 million) and net loss of ¥132 million (compared with net loss of ¥291 million).」
Net sales increased 21.5% from the previous fiscal year, and operating, ordinary and net losses all narrowed, but the company remained in the red. - FY2023-Q3Revenue Growth and Reduced LossesAnnual report
「As a result, net sales for the nine months ended the third quarter amounted to ¥1,922 million (up 25.8% year on year). In terms of earnings, higher sales increased gross profit, while lower selling, general and administrative expenses, mainly due to reduced research and development and recruiting expenses, resulted in an operating loss of ¥79 million (compared with operating loss of ¥337 million in the same quarter of the previous year), ordinary loss of ¥87 million (compared with ordinary loss of ¥341 million) and quarterly net loss of ¥99 million (compared with quarterly net loss of ¥481 million).」
Net sales increased 25.8% year on year, and operating, ordinary and quarterly net losses all narrowed substantially from the same quarter of the previous year. However, losses at each level continued. - FY2023-Q2Revenue Growth and Reduced LossesAnnual report
「As a result, net sales for the six months ended the second quarter amounted to ¥1,266 million (up 30.8% year on year). In terms of earnings, higher sales increased gross profit, while lower selling, general and administrative expenses, mainly due to reduced research and development and recruiting expenses, resulted in an operating loss of ¥52 million (compared with operating loss of ¥263 million in the same quarter of the previous year), ordinary loss of ¥59 million (compared with ordinary loss of ¥266 million) and quarterly net loss of ¥69 million (compared with quarterly net loss of ¥378 million).」
Net sales increased 30.8% year on year, and operating, ordinary and quarterly net losses all narrowed from the same quarter of the previous year. However, losses continued. - FY2023-Q1Revenue Growth and Reduced LossesAnnual report
「As a result, net sales for the three months ended the first quarter amounted to ¥619 million (up 30.5% year on year). In terms of earnings, higher sales increased gross profit, while lower selling, general and administrative expenses, mainly due to reduced research and development expenses, resulted in an operating loss of ¥35 million (compared with operating loss of ¥151 million in the same quarter of the previous year), ordinary loss of ¥36 million (compared with ordinary loss of ¥154 million) and quarterly net loss of ¥44 million (compared with quarterly net loss of ¥154 million).」
Net sales increased 30.5% year on year, and operating, ordinary and quarterly net losses all narrowed from the same quarter of the previous year. However, the company remained in the red. - FY2022Revenue Growth and Reduced LossesAnnual report
「As a result, net sales for the fiscal year amounted to ¥2,119 million (up 4.0% from the previous fiscal year). In terms of earnings, lower cost of sales, mainly due to reduced depreciation and amortization, and lower selling, general and administrative expenses, particularly research and development expenses, resulted in an operating loss of ¥378 million (compared with operating loss of ¥596 million in the previous fiscal year), ordinary loss of ¥382 million (compared with ordinary loss of ¥611 million) and net loss of ¥291 million (compared with net loss of ¥786 million).」
Net sales increased 4.0% from the previous fiscal year, and operating, ordinary and net losses all narrowed. However, operating losses and other losses continued. - FY2022-Q3Lower sales, narrower operating loss and narrower net lossAnnual report
「As a result, net sales for the nine months ended the third quarter amounted to ¥1,528 million (down 0.8% year on year). In terms of earnings, lower cost of sales, mainly due to reduced depreciation and amortization, and lower selling, general and administrative expenses, particularly research and development expenses, resulted in an operating loss of ¥337 million (compared with operating loss of ¥490 million in the same quarter of the previous year) and ordinary loss of ¥341 million (compared with ordinary loss of ¥500 million). Quarterly net loss was ¥481 million (compared with quarterly net loss of ¥490 million), due to an impairment loss on fixed assets being recorded as an extraordinary loss.」
While net sales fell 0.8% year on year, the operating loss narrowed from ¥490 million to ¥337 million, the ordinary loss from ¥500 million to ¥341 million, and the net loss from ¥490 million to ¥481 million. - FY2022-Q2Lower sales, narrower operating loss and wider net lossAnnual report
「As a result, net sales for the six months ended the second quarter amounted to ¥967 million (down 4.8% year on year). In terms of earnings, although gross profit declined due to lower sales, reduced selling, general and administrative expenses, mainly research and development expenses, resulted in an operating loss of ¥263 million (compared with operating loss of ¥352 million in the same quarter of the previous year) and ordinary loss of ¥266 million (compared with ordinary loss of ¥361 million). Quarterly net loss was ¥378 million (compared with quarterly net loss of ¥335 million), due to an impairment loss on fixed assets being recorded as an extraordinary loss.」
While net sales fell 4.8% year on year, operating and ordinary losses narrowed due to lower selling, general and administrative expenses, particularly research and development expenses. However, quarterly net loss widened due to an impairment loss on fixed assets. - FY2022-Q1Lower revenue and narrower lossesAnnual report
「As a result, net sales for the three months ended the first quarter amounted to ¥474 million (down 7.9% year on year). In terms of earnings, although gross profit declined due to lower sales, reductions in selling, general and administrative expenses, including research and development expenses, resulted in an operating loss of ¥151 million (compared with operating loss of ¥183 million in the same quarter of the previous year), ordinary loss of ¥154 million (compared with ordinary loss of ¥184 million) and quarterly net loss of ¥154 million (compared with quarterly net loss of ¥157 million).」
While net sales fell 7.9% year on year, the operating, ordinary and net loss amounts narrowed from the same quarter of the previous year due mainly to lower selling, general and administrative expenses. - FY2021WorsenedAnnual report
「As a result, net sales for the fiscal year amounted to ¥2,037 million (down 4.0% from the previous fiscal year). In terms of earnings, higher recruiting expenses and research and development expenses resulted in an operating loss of ¥596 million (compared with operating loss of ¥176 million in the previous fiscal year). Ordinary loss was ¥611 million (compared with ordinary loss of ¥207 million), due to various expenses related to the issuance of stock acquisition rights, and net loss was ¥786 million (compared with net loss of ¥260 million), due partly to impairment losses on fixed assets and software valuation losses being recorded as extraordinary losses.」
Full-year net sales fell 4.0%, while the operating loss widened from ¥176 million to ¥596 million, the ordinary loss from ¥207 million to ¥611 million, and the net loss from ¥260 million to ¥786 million. - FY2021-Q3WorsenedAnnual report
「As a result, net sales for the nine months ended the third quarter amounted to ¥1,540 million (down 3.4% year on year). In terms of earnings, higher recruiting and personnel expenses and research and development expenses resulted in an operating loss of ¥490 million (compared with operating loss of ¥56 million in the same quarter of the previous year). Ordinary loss was ¥500 million (compared with ordinary loss of ¥87 million), due to various expenses related to the issuance of stock acquisition rights, and quarterly net loss was ¥490 million (compared with quarterly net loss of ¥107 million).」
Net sales fell 3.4% year on year, while the operating loss widened from ¥56 million to ¥490 million, the ordinary loss from ¥87 million to ¥500 million, and the quarterly net loss from ¥107 million to ¥490 million. Recruiting expenses, personnel expenses, research and development expenses and expenses related to the issuance of stock acquisition rights are cited as factors. - FY2021-Q2WorsenedAnnual report
「As a result, net sales for the six months ended the second quarter amounted to ¥1,016 million (down 3.5% year on year). In terms of earnings, expenses related to recruiting and personnel expenses, as well as higher research and development expenses for the innovation business, resulted in an operating loss of ¥352 million (compared with operating loss of ¥27 million in the same quarter of the previous year). Ordinary loss was ¥361 million (compared with ordinary loss of ¥58 million), due to various expenses related to the issuance of stock acquisition rights, and quarterly net loss was ¥335 million (compared with quarterly net loss of ¥82 million).」
Net sales fell 3.5% year on year, and operating, ordinary and net losses widened from the same quarter of the previous year. Recruiting expenses, personnel expenses, research and development expenses and expenses related to the issuance of stock acquisition rights are cited as factors. - FY2021-Q1WorsenedAnnual report
「As a result, net sales for the three months ended the first quarter amounted to ¥515 million (down 3.0% year on year). In terms of earnings, higher personnel expenses due to an increase in employees and higher research and development expenses resulted in an operating loss of ¥183 million (compared with operating profit of ¥4 million in the same quarter of the previous year), ordinary loss of ¥184 million (compared with ordinary loss of ¥25 million) and quarterly net loss of ¥157 million (compared with quarterly net loss of ¥19 million).」
Net sales declined year on year, and operating, ordinary and quarterly net losses widened. Higher personnel and research and development expenses are cited as factors behind the operating loss. - FY2020WorsenedAnnual report
「As a result, net sales for the fiscal year amounted to ¥2,122 million (down 21.0% from the previous fiscal year). In terms of earnings, the decline in sales and a substantial increase in research and development expenses, among other factors, resulted in an operating loss of ¥176 million (compared with operating profit of ¥272 million in the previous fiscal year). Ordinary loss was ¥207 million (compared with ordinary profit of ¥269 million in the previous fiscal year), due to various expenses related to the transfer to the Tokyo Stock Exchange’s First Section being recorded as non-operating expenses, and net loss was ¥260 million (compared with net profit of ¥203 million in the previous fiscal year), due partly to the reversal of deferred tax assets.」
The decline in sales widened from the previous fiscal year, and operating profit, ordinary profit and net profit all changed to losses. - FY2020-Q3WorsenedAnnual report
「As a result, net sales for the nine months ended the third quarter amounted to ¥1,594 million (down 23.1% year on year). In terms of earnings, the decline in sales and an increase in research and development expenses, among other factors, resulted in an operating loss of ¥56 million (compared with operating profit of ¥240 million in the same quarter of the previous year). Ordinary loss was ¥87 million (compared with ordinary profit of ¥237 million in the same quarter of the previous year), due to various expenses related to listing on the Tokyo Stock Exchange’s First Section being recorded as non-operating expenses, and quarterly net loss was ¥107 million (compared with quarterly net profit of ¥159 million in the same quarter of the previous year).」
Net sales fell 23.1% year on year, while the operating, ordinary and net loss amounts all widened, indicating that the decline in sales and shift into the red has progressed. - FY2020-Q2WorsenedAnnual report
「As a result, net sales for the six months ended the second quarter amounted to ¥1,053 million (down 26.0% year on year). In terms of earnings, the decline in sales and an increase in research and development expenses, among other factors, resulted in an operating loss of ¥27 million (compared with operating profit of ¥166 million in the same quarter of the previous year). Ordinary loss was ¥58 million (compared with ordinary profit of ¥165 million in the same quarter of the previous year), due to various expenses related to listing on the Tokyo Stock Exchange’s First Section being recorded as non-operating expenses, and quarterly net loss was ¥82 million (compared with quarterly net profit of ¥110 million in the same quarter of the previous year).」
The year-on-year decline in sales widened, and the company recorded operating, ordinary and quarterly net losses, indicating that the decline in sales and shift into the red seen through the previous quarter has progressed. - FY2020-Q1Lower sales and a return to lossesAnnual report
「As a result, net sales for the three months ended the first quarter amounted to ¥531 million (down 16.1% year on year), as orders for the consulting business decreased compared with the same quarter of the previous year. In terms of earnings, gross profit declined due to lower sales, resulting in operating profit of ¥4 million (down 90.9%). Ordinary loss was ¥25 million (compared with ordinary profit of ¥51 million in the same quarter of the previous year), due to various expenses related to listing on the Tokyo Stock Exchange’s First Section being recorded as non-operating expenses, and quarterly net loss was ¥19 million (compared with quarterly net profit of ¥33 million in the same quarter of the previous year).」
Net sales declined year on year, operating profit fell sharply, and the company changed to an ordinary loss and quarterly net loss. - FY2019Decline in Sales and EarningsAnnual report
「Net sales amounted to ¥2,684 million (down 11.2% from the previous fiscal year). In terms of earnings, the effect of the one-time payment related to licensing rights recorded in the previous fiscal year ceased, among other factors, resulting in operating profit of ¥272 million (down 26.6%), ordinary profit of ¥269 million (down 24.6%) and net profit of ¥203 million (down 17.1%).」
The results changed from higher sales and higher profit in the previous fiscal year, with net sales and each profit measure declining year on year in the current fiscal year. - FY2019-Q3RestatedAnnual report
「As a result, net sales for the nine months ended the third quarter amounted to ¥2,074 million (down 2.0% year on year), as personnel and other management resources had been allocated to strengthening the structure of the innovation business, despite solid orders for the consulting business. In terms of earnings, gross profit increased due mainly to the effect of higher consulting-business revenue, resulting in operating profit of ¥240 million (up 2.6%), ordinary profit of ¥237 million (up 8.0%) and quarterly net profit of ¥159 million (up 6.0%).」
The results showed the same “lower sales and higher profit” pattern as in the previous quarter: net sales fell 2.0% year on year due mainly to the allocation of management resources to the innovation business, while operating profit, ordinary profit and quarterly net profit increased. - FY2019-Q2Lower sales and higher profitAnnual report
「Although orders for the consulting business remained solid, net sales fell to ¥1,423 million (down 3.1% year on year) due mainly to a decrease in deliveries of the “ユニケージ” batch-processing acceleration solution for financial institutions compared with the same quarter of the previous year. Gross profit increased, reflecting expanded orders for the consulting business, among other factors, resulting in operating profit of ¥166 million (up 18.8%), ordinary profit of ¥165 million (up 21.0%) and quarterly net profit of ¥110 million (up 11.2%).」
While net sales fell 3.1% year on year due mainly to lower deliveries of ユニケージ, operating profit, ordinary profit and quarterly net profit increased, reflecting expanded orders for the consulting business, among other factors. - FY2019-Q1RestatedAnnual report
「As a result, for the cumulative first-quarter period under review, revenue was ¥633 million, operating income was ¥52 million, ordinary income was ¥51 million and net income for the quarter was ¥33 million.」
Net sales, operating profit, ordinary profit and net profit for the first quarter are disclosed in detail. No comparative analysis was conducted against the same quarter of the previous year, so the results are not characterized as having expanded. - FY2018AdvancedAnnual report
「As a result, for the fiscal year under review, revenue was ¥3,024 million, up 75.5% year on year, operating income was ¥370 million, up 115.9%, ordinary income was ¥357 million, up 114.3%, and net income was ¥245 million, up 130.3%.」
Full-year revenue and each profit measure increased substantially year on year, demonstrating the expansion in business performance through specific figures. - FY2018-Q3First statedAnnual report
「As a result, for the cumulative third-quarter period under review, revenue was ¥2,116 million, operating income was ¥234 million, ordinary income was ¥220 million and net income for the quarter was ¥150 million.」
Revenue, operating income, ordinary income and net income for the quarter are presented as the results for the cumulative third-quarter period.